VERA
VERA
NASDAQ · Biotechnology

Vera Therapeutics Inc

$40.53
-0.84 (-2.03%)
As of Mar 22, 9:58 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 3 15%
Sell 0 0%
Price Target
Analyst Price Target +133.4% upside
Low Target $72.50
Average Target $94.61
High Target $144.94
Current Price $40.53
Current
$40.53
Target
$94.61
$72.50 $94.61 avg $144.94
Scenario Analysis
Bear Case
$72.50
78.9%
Low target
Base Case
$94.61
+133.4%
Avg target
Bull Case
$144.94
+257.6%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$56.05
-27.7% from high
52-Week Low
$18.53
+118.7% from low
50-Day SMA
$46.91
-13.6% vs SMA
200-Day SMA
$30.68
+32.1% vs SMA
RSI (14)
41.5
Neutral
Target vs 52W High
$94.61
+68.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -26.5%